MedPath

In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens

Not Applicable
Completed
Conditions
Astigmatism
Interventions
Device: senofilcon A toric contact lens
Device: alphafilcon A toric
Device: etafilcon A sphere
Registration Number
NCT00584727
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric and a spherical contact lens currently available in market, specifically with regards to the fit and visual acuity as well as the comfort, vision and satisfaction while in the practitioner's office. Approximately 2 hours duration.

Detailed Description

Non-dispensing, single-masked (subject-masked), randomised, controlled study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria
  1. be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
  2. be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy
  3. have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
  4. be able and willing to adhere to the instructions set forth in the protocol.
  5. agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  6. have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
  7. have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
  8. be in good general health, based on his/her knowledge.
  9. read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.
Exclusion Criteria
  1. The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.

  2. The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.

  3. The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).

  4. Slit lamp findings that would contraindicate contact lens wear such as:

    • Pathological dry eye or associated findings
    • Pterygium or corneal scars within the visual axis
    • Neovascularization >1mm in from the limbus
    • History of giant papillary conjunctivitis (GPC) worse than Grade 2
    • Anterior uveitis or iritis (past or present)
    • Seborrhoeic eczema, seborrhoeic conjunctivitis
  5. A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.

  6. A known history of corneal hypoesthesia (reduced corneal sensitivity.)

  7. Aphakia, keratoconus or a highly irregular cornea.

  8. Current pregnancy or lactation (to the best of the subject's knowledge).

  9. Active participation in another clinical study at any time during this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
senofilcon A/alphafilcon A/etafilcon Aalphafilcon A toricFirst intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
alphafilcon A/etafilcon A/senofilcon Aalphafilcon A toricFirst intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses
alphafilcon A/etafilcon A/senofilcon Aetafilcon A sphereFirst intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses
etafilcon A/senofilcon A/alphafilcon Aetafilcon A sphereFirst intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses
senofilcon A/etafilcon A/alphafilcon Asenofilcon A toric contact lensFirst intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses
senofilcon A/alphafilcon A/etafilcon Asenofilcon A toric contact lensFirst intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
senofilcon A/alphafilcon A/etafilcon Aetafilcon A sphereFirst intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
etafilcon A/senofilcon A/alphafilcon Aalphafilcon A toricFirst intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses
alphafilcon A/etafilcon A/senofilcon Asenofilcon A toric contact lensFirst intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses
senofilcon A/etafilcon A/alphafilcon Aalphafilcon A toricFirst intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses
etafilcon A/alphafilcon A/senofilcon Asenofilcon A toric contact lensFirst intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses
etafilcon A/alphafilcon A/senofilcon Aalphafilcon A toricFirst intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses
etafilcon A/senofilcon A/alphafilcon Asenofilcon A toric contact lensFirst intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses
senofilcon A/etafilcon A/alphafilcon Aetafilcon A sphereFirst intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses
alphafilcon A/senofilcon A/etafilcon Asenofilcon A toric contact lensFirst intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
alphafilcon A/senofilcon A/etafilcon Aalphafilcon A toricFirst intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
alphafilcon A/senofilcon A/etafilcon Aetafilcon A sphereFirst intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses
etafilcon A/alphafilcon A/senofilcon Aetafilcon A sphereFirst intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses
Primary Outcome Measures
NameTimeMethod
Visual Acuity15-20 minutes

Number of eyes with Distance Visual Acuity 20/20 or better

Lens Stability Within 5 Degrees1 minute

Measures if the lens changes position on the eye as it is worn and is measured in degrees of rotation.

Patient Reported Vision15-20 minutes

A weighted combined score calculated from individual confort-vision related questions asked on a 1-5 scale, 1=most negative resonse to 5=most positive response, was used to derive vision scores. The analysis shows the difference in outcome between test and control. \>0=greater vision, \<0=lesser vision.

Lens Orientation Within 5 Degrees1 minute

Meaures in what position does the lens sit on the eye at insertion and is measured in degrees of rotation.

Patient Reported Comfort.15-20 minutes

A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. \>0=comfortable, \<0=uncomfortable

Patient Preferenceend of study

This outcome measures which lens the subjects preferred to wear.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath